tangeretin has been researched along with epidermal growth factor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arroo, R; Boarder, MR; Cheng, Z; Ruparelia, K; Surichan, S | 1 |
1 other study(ies) available for tangeretin and epidermal growth factor
Article | Year |
---|---|
Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Epidermal Growth Factor; Flavones; Hepatocytes; Humans; Male; Phosphorylation; Prodrugs; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2011 |